When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?

L. S. Freedman, P. Workman

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

We describe a simple and rapid method to determine the amount by which the area under the curve (AUC) is underestimated when a drug is given by i.v. infusion but the infusion period is ignored and the post-infusion data are analysed as if they derive from a bolus injection. Charts are provided that allow the investigator to determine the approximate underestimation for drugs following the one- and two-compartment models, and hence to decide whether it is acceptable to ignore the infusion period in a given case (e.g., underestimation < 5% or 10%). Equations are also provided that allow the exact underestimation to be calculated, together with the true value of the AUC.

Original languageEnglish
Pages (from-to)95-103
Number of pages9
JournalCancer Chemotherapy and Pharmacology
Volume22
Issue number2
DOIs
StatePublished - Aug 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?'. Together they form a unique fingerprint.

Cite this